Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 32001 - 32025 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cisplatin	Approved Investigational	RSL1D1	26156	upregulated	Cisplatin results in increased expression of RSL1D1 mRNA	16p13.13	A20427
Cisplatin	Approved Investigational	RSRC1	51319	downregulated	Cisplatin results in decreased expression of RSRC1 mRNA	3q25.32	A22203
Cisplatin	Approved Investigational	RSRC1	51319	upregulated	Cisplatin results in increased expression of RSRC1 mRNA	3q25.32	A22204
Cisplatin	Approved Investigational	RSRC2	65117	downregulated	Cisplatin results in decreased expression of RSRC2 mRNA	12q24.31	A20427
Cisplatin	Approved Investigational	RSRP1	57035	upregulated	Cisplatin results in increased expression of RSRP1 mRNA	1p36.11	A22211
Cisplatin	Approved Investigational	RTKN	6242	downregulated	Cisplatin results in decreased expression of RTKN mRNA	2p13.1	A22203
Cisplatin	Approved Investigational	RUNX1	861	downregulated	Cisplatin results in decreased expression of RUNX1 mRNA	21q22.12	A20427
Cisplatin	Approved Investigational	RUNX3	864	downregulated	Cisplatin results in decreased expression of RUNX3 mRNA	1p36.11	A20660
Cisplatin	Approved Investigational	S100A6	6277	upregulated	Cisplatin results in increased expression of S100A6 mRNA	1q21.3	A22203
Cisplatin	Approved Investigational	S100P	6286	upregulated	Cisplatin results in increased expression of S100P mRNA	4p16.1	A22261
Cisplatin	Approved Investigational	SAA1	6288	upregulated	Cisplatin results in increased expression of SAA1 mRNA	11p15.1	A22210
Cisplatin	Approved Investigational	SAC3D1	29901	upregulated	Cisplatin results in increased expression of SAC3D1 mRNA	11q13.1	A22204
Cisplatin	Approved Investigational	SAP30	8819	downregulated	Cisplatin results in decreased expression of SAP30 mRNA	4q34.1	A22211
Cisplatin	Approved Investigational	SARS	6301	upregulated	Cisplatin results in increased expression of SARS mRNA	1p13.3	A20427
Cisplatin	Approved Investigational	SCFD2	152579	downregulated	Cisplatin results in decreased expression of SCFD2 mRNA	4q12	A22204
Cisplatin	Approved Investigational	SCN3B	55800	upregulated	Cisplatin results in increased expression of SCN3B mRNA	11q24.1	A22212
Cisplatin	Approved Investigational	SDC1	6382	downregulated	Cisplatin results in decreased expression of SDC1 mRNA	2p24.1	A21499
Cisplatin	Approved Investigational	SDC4	6385	upregulated	Cisplatin results in increased expression of SDC4 mRNA	20q13.12	A22203
Cisplatin	Approved Investigational	SDF2L1	23753	upregulated	Cisplatin results in increased expression of SDF2L1 mRNA	22q11.21	A22204
Cisplatin	Approved Investigational	SDHAF1	644096	downregulated	Cisplatin results in decreased expression of SDHAF1 mRNA	19q13.12	A21499
Cisplatin	Approved Investigational	SEC62	7095	upregulated	Cisplatin results in increased expression of SEC62 mRNA	3q26.2	A22204
Cisplatin	Approved Investigational	SELENOK	58515	upregulated	Cisplatin results in increased expression of SELENOK mRNA	3p21.1	A22204
Cisplatin	Approved Investigational	SELENOS	55829	upregulated	Cisplatin results in increased expression of SELENOS mRNA	15q26.3	A22204
Cisplatin	Approved Investigational	SEMA4D	10507	downregulated	Cisplatin results in decreased expression of SEMA4D mRNA	9q22.2	A22204
Cisplatin	Approved Investigational	SERP1	27230	upregulated	Cisplatin results in increased expression of SERP1 mRNA	3q25.1	A22204

Displaying entries 32001 - 32025 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability